BluGlass gains room to scale with A$5.5 million in new liquidity
3 min read
12:42pm on Wednesday 23rd of September, 2026 AEST ~12pm, 23rd Sept, 26
BluGlass has agreed an A$8.0 million R&D-backed loan with Rockford, refinancing its existing Radium facility and adding about A$5.5 million of liquidity. The funding gives the laser developer more room to scale, but carries a 16.5% interest rate and repayment obligations tied to future tax refunds.
- A$8.0 million Rockford R&D financing facility agreed
- Approximately A$5.5 million of incremental liquidity after refinancing
- 16.5% annual interest rate and 2.5% establishment fee
- Repayment secured against FY26 and FY27 R&D Tax Incentive refunds
- Funding earmarked for working capital, production scaling and laser development
A$5.5 Million Liquidity Lift
BluGlass Limited (ASX:BLG) has secured a new A$8.0 million research and development financing facility that will leave the gallium nitride laser developer with approximately A$5.5 million in additional liquidity after refinancing its existing A$2.27 million Radium facility. The funding is intended to support working capital and growth initiatives, including production expansion and the conversion of revenue opportunities.
The agreement with Rockford RDF Pty Ltd as trustee for the Rockford RDF Unit Trust is significant less for the headline facility size than for the cash it makes available beyond the refinancing. BluGlass has agreed terms, but the announcement does not provide a settlement or drawdown date, so the immediate availability of the additional funds remains a practical point to track.
High-Cost Funding Against Tax Refunds
The facility carries interest of 16.5% per annum and a 2.5% establishment fee. Of that fee, A$100,000 will be capitalised into the loan balance and another A$100,000 will be paid in BluGlass shares. The cost of the financing is therefore material, even before the company begins using the incremental liquidity to pursue its operating plans.
Repayment is structured around BluGlass’ anticipated R&D Tax Incentive refunds. A$2.75 million is scheduled to be repaid from the FY26 refund, with the remaining balance to be repaid from the FY27 refund and no later than 1 March 2028. The facility has first-ranking security over those refunds, alongside a limited featherweight security over the company’s other assets.
Production Scaling and Laser Development
Chief executive and managing director Jim Haden said the facility would provide early access to anticipated tax refunds and help BluGlass scale production, convert revenue opportunities and continue developing laser solutions for quantum sensing, advanced manufacturing and defence markets. Those plans are stated objectives rather than disclosed financial outcomes, and the announcement does not attach revenue targets or production milestones to the funding.
The financing gives BluGlass more operating capacity while shifting part of the funding risk into future tax receipts. Its usefulness will depend on how quickly the company can deploy the additional liquidity and whether the anticipated FY26 and FY27 refunds arrive in the amounts and timing needed to meet the scheduled repayments. The next points of substance are likely to be completion of the refinancing, evidence of production progress and the eventual size of those refunds.
Bottom Line?
BluGlass has bought additional operating room, but at a steep interest cost and with repayment anchored to future R&D tax refunds.
Questions in the middle?
- When will the Rockford facility be completed and the additional liquidity become available?
- Can BluGlass convert the funding into production and revenue progress quickly enough to justify its cost?
- Will the FY26 and FY27 R&D Tax Incentive refunds be sufficient and timely for the scheduled repayments?
